Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-017478
Filing Date
2022-08-16
Accepted
2022-08-16 06:03:02
Documents
69
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cala-20220630.htm   iXBRL 10-Q 3650883
2 EX-10.1 cala-ex10_1.htm EX-10.1 54350
3 EX-31.1 cala-ex31_1.htm EX-31.1 16121
4 EX-31.2 cala-ex31_2.htm EX-31.2 15690
5 EX-32.1 cala-ex32_1.htm EX-32.1 11294
6 EX-32.2 cala-ex32_2.htm EX-32.2 11172
  Complete submission text file 0000950170-22-017478.txt   10958529

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cala-20220630.xsd EX-101.SCH 56854
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cala-20220630_def.xml EX-101.DEF 203981
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cala-20220630_pre.xml EX-101.PRE 363810
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cala-20220630_cal.xml EX-101.CAL 45665
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cala-20220630_lab.xml EX-101.LAB 470046
63 EXTRACTED XBRL INSTANCE DOCUMENT cala-20220630_htm.xml XML 1989042
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

EIN.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36644 | Film No.: 221168367
SIC: 2834 Pharmaceutical Preparations